AI eye doctor: new study aims to spot Blindness-Causing diseases faster
NCT ID NCT07249307
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a new artificial intelligence (AI) system that reads eye scans (OCT) to diagnose common blinding eye diseases like diabetic retinopathy, glaucoma, and age-related macular degeneration. Researchers will collect 2000 eye scans from patients at Peking Union Medical College Hospital and see how well the AI can identify each disease. The goal is to create a faster, more reliable way to diagnose these conditions using AI.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION (AMD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a bangkok community eye check reveal hidden glaucoma risks?
- AI eye exam: a new hope for early glaucoma detection?
- Can a tiny eye implant replace glaucoma drops?
- Can a new tube implant surgery outperform standard glaucoma surgery?
- Can a One-Time gene therapy offer lasting protection for diabetic retinopathy?
- Can At-Home eye scans personalize wet AMD treatment?